GlassScriptPhysician profile
Sunandan Pandya
NPI 1104897487
$10,905.72
in general payments reported to CMS, 2019-2025
18 companies · $3,266 in 2025
The $3,266 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,567 · 2020: $99.66 · 2021: $545 · 2022: $2,046 · 2023: $921 · 2024: $1,461 · 2025: $3,266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,484 · Travel and Lodging: $1,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,483.89 |
| Travel and Lodging | $1,164.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,772.45 | 2019-2025 | Watchman Flx, General - Therapies, Watchman Access System |
| Abbott Laboratories | $1,852.13 | 2021-2025 | Triclip, Amplatzer Amulet, Cardiomems |
| Astrazeneca Pharmaceuticals LP | $603.86 | 2019-2025 | Tezspire |
| Novartis Pharmaceuticals Corporation | $203.92 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $181.53 | 2019-2025 | Eliquis, Camzyos |
| Bridgebio Pharma, INC. | $169.90 | 2025 | Attruby |
| Bayer Healthcare Pharmaceuticals INC. | $143.41 | 2022-2025 | |
| Stryker Corporation | $136.53 | 2024 | Mako |
| Seapearl East, INC | $126.27 | 2024 | |
| Novo Nordisk INC | $125.00 | 2019 | |
| Pfizer INC. | $125.00 | 2019 | |
| Impulse Dynamics (USA) INC. | $107.98 | 2023 | Optimizer |
| Corcept Therapeutics | $98.94 | 2025 | Korlym |
| Merck Sharp & Dohme LLC | $97.59 | 2023-2025 | Verquvo, Capvaxive |
| Amgen INC. | $93.01 | 2025 | Repatha, Repatha |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $31.25 | 2024 | Barostim Neo System |
| Philips North America LLC | $22.91 | 2024 | (5091) Amb Mon & Diag Und |
| Janssen Pharmaceuticals, INC | $14.04 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunandan Pandya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.